OncLive - Bringing the Oncology Community Together

To ease the administrative burden, CMS has facilitated the collection and processing of information by allowing the formulation of Qualified Clinical Data Registries, which collect data on quality measures from individual... Read More >>

Patel Provides Perspective on Immunotherapy Developments in NSCLC

COG Addresses Unmet Needs in Pediatric NHL

FDA Delays Decision on Lenvatinib for HCC

Durvalumab Improves Survival in Stage III NSCLC

Selinexor Tested in Combination With Standard Therapy in Multiple Myeloma

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Genitourinary Cancers

2018 ASCO Annual Meeting

2018 ASPHO Conference

2018 State of the Science Summit on Genitourinary Cancers

2018 State of the Science Summit on Gastrointestinal Cancers

Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian Cancer

Dr. Succaria on Combination Immunotherapy in Head and Neck Cancer

Dr. Snyder Discusses Emerging Agents in Myelofibrosis

Dr. Htut on Immunotherapy in Multiple Myeloma

Dr. Slamon on PARP Inhibitors in Ovarian Cancer

Dr. Cohen on the Evolution of Surgery in Ovarian Cancer

Dr. Kopetz Discusses Triplet Therapy for BRAF-Mutant CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

Renal Cell Carcinoma: An Evolving Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Continuing Therapy in Relapsed/Refractory CLL$

Continuing Therapy in Relapsed/Refractory CLL

The Continuum of Care in NSCLC

NSCLC Patients and Education About Therapy

Precision Medicine for NSCLC and the Role of APPs

Importance of Tumor Boards in NSCLC Management

How Much Tissue Do You Need for NSCLC Diagnosis?

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

Relapsed/Refractory ALL: Evaluating Novel Agents

$Relapsed/Refractory ALL: Evaluating Novel Agents$
A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval of Biosimilar, Proposed Change in US Drug Prices, and 2018 ASCO Presscast